Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study

Abstract Background We assessed the impact of 24 months of treatment with ipragliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on endothelial function in patients with type 2 diabetes as a sub-analysis of the PROTECT study. Methods In the PROTECT study, patients were randomized to rece...

Descrición completa

Detalles Bibliográficos

Principais autores:	Shinji Kishimoto, Yukihito Higashi, Takumi Imai, Kazuo Eguchi, Kazuo Fukumoto, Hirofumi Tomiyama, Koji Maemura, Atsushi Tanaka, Koichi Node, the PROTECT investigators
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-05-01
Series:	Cardiovascular Diabetology
Assuntos:	Ipragliflozin Sodium-glucose cotransporter-2 inhibitors Endothelial function Type 2 diabetes
Acceso en liña:	https://doi.org/10.1186/s12933-023-01856-x
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!